Intermediate versus low or high prostate-specific antigen density level: Comparison of cancer detection rate between 12- and 18-core prostate biopsy

Scandinavian Journal of Urology and Nephrology

Volumn 44, Issue 6, 2010, Pages 391-398

  Park, Ho Ki ^a   Lee, Kwang Yeom ^a   Kim, Khae Hawn ^a   Jung, Han ^a   Yoon, Sang Jin ^a   Kim, Tae Beom ^a  

^a Gachon University   (South Korea)

Author keywords

Biopsy; Prostate cancer; Prostate specific antigen; Prostate specific antigen density

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 78649261979     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2010.508049     Document Type: Article

References (28)

1. Astraldi A. Diagnosis of cancer of the prostate; biopsy by rectal route. Urol Cutan Rev 1937;41:421-7.
2. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989;142:66-70.
3. Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology 1998;52:808-13.
4. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998;159:471-5.
5. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997;49:113-8.
6. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-92.
7. Fleshner NE, O'Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997;158:505-9. (Pubitemid 27327697)
8. Jeong H, Jeong BC, Kwak C, Lee E, Lee SE, Kim TB. A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men. World J Urol 2008;26:395-400.
9. Ecke TH, Gunia S, Bartel P, Hallmann S, Koch S, Ruttloff J. Complication and risk factor of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire. Urol Oncol 2008;26:474-8.
10. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997;50:562-6.
11. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571-4.
12. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997;158:2168-75.
13. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605-12.
14. Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive biopsy for prostate cancer. J Urol 2005;173:421-4.
15. Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indication and technique. J Urol 2003;169:12-9.
16. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography- guided prostate biopsy protocol. BJU Int 2002;89:33-9.
17. Matsumoto K, Satoh T, Egawa S, Shimura S, Kuwao S, Baba S. Efficacy and morbidity of transrectal ultrasoundguided 12-core biopsy for detection of prostate cancer in Japanese men. Int J Urol 2005;12:353-60.
18. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000;164:388-92.
19. Ung JO, San Fancisco IF, Regan MM, De Wolf WC, Olumi AF. The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol 2003;169:130-5.
20. Scattoni V, Roscigno M, Raber M, Deho F, Maga T, Zanoni M, et al. Initial extended transrectal prostate biopsy - are more prostate cancers detected with 18 cores than with 12 cores? J Urol 2008;179:1327-31.
21. de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A, et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003;61:1181-6.
22. Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, et al. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. Urology 2006;68:815-9.
23. Song C, Ro JY, Lee MS, Hong SJ, Chung BH, Choi HY, et al. Prostate cancer in Korea men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 2006;68:820-4.
24. Hong SK, Yu JH, Han BK, Chang IH, Jeong SJ, Byun SS, et al. Association of prostate cancer size and tumor grade in Korean men with clinically localized prostate cancer. Urology 2007;70:91-5.
25. Berger AP, Gozzi C, Steiner H, Frauscher F, Varkarakis J, Rogatsch H, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171:1478-81.
26. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999-2001; first results using the National Cancer Incidence Database. Cancer Res Treat 2005;37:325-31.
27. Korea National Statistical Office. The cause of death statistics, 1983-2003. Korea: Korea National Statistical Office; 2005.
28. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005;41:834-45.